Heparin, the most widely used anticoagulant drug in the world today, remains an animal-
derived product with the attendant risks of adulteration and contamination. A contamination …

Heparin is one of the oldest biological medicines, and has an established place in the
prevention and treatment of venous thrombosis. Low-molecular-weight heparins (LMWH) …

Immune checkpoint inhibitors (ICIs) are the standard of care for the treatment of several
cancers. While these immunotherapies have improved patient outcomes in many clinical …

This article discusses the prevention of venous thromboembolism (VTE) and is part of the
Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence …

Te Linde's Operative Gynecology has been the premier text in the field of gynecologic
surgery for more than 60 years. This text covers all of the aspects of gynecologic surgery …

Purpose Advanced pancreatic cancer (APC), in addition to its high mortality, accounts for the
highest rates of venous thromboembolic events (VTEs). Enoxaparin, a low–molecular weight …

Background: Identifying previously undiagnosed cancer in patients with newly diagnosed
venous thromboembolism (VTE) is important. Screening for malignant conditions can …

Purpose: Heparanase promotes myeloma growth, dissemination, and angiogenesis through
modulation of the tumor microenvironment, thus highlighting the potential of therapeutically …

The platelet aggregation-inducing factor Aggrus, also known as podoplanin, is frequently
upregulated in several types of tumors and enhances hematogenous metastasis by …

Pathogenesis of the prothrombotic state of cancer patients is due, at least in part, to the
ability of cancer cells to activate the coagulation system. Several complex and not fully …